By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

ViraCyte 

2450 Holcombe Boulevard

Houston  Texas  77021  U.S.A.
Phone: 346-772-0319 Fax: n/a


SEARCH JOBS

ViraCyte is a clinical stage biopharmaceutical company focused on discovering and developing cellular immunotherapies for severe life threatening infections. ViraCyte's current products restore natural immunity against life threatening viruses in patients with severely weakened immune systems, such as adults and children who have recently undergone a hematopoietic stem cell transplant (HSCT). ViraCyte's lead T cell products are in Phase 1 and Phase 2 clinical trials, with effectiveness rates of greater than 90% in patients who have failed conventional therapy. More information can be found at www.viracyte.com.

YEAR FOUNDED:

2013

LEADERSHIP:

Co-Founder: Juan Vera

Co-Founder: Ann Leen

CEO and President: Brett P. Giroir, MD

Chief Product Development Officer: Juan F. Vera, MD

CSO: Ann M. Leen, PhD

Director, Regulatory Affairs: Bambi J. Grilley,RPh, RAC, CIP, CCRC, CCRP

Managing Director: John R. Wilson

SCIENCE:

Please click here for ViraCyte's science.

PIPELINE:

Please click here for ViraCyte's pipeline.


Key Statistics


Email: info@viracyte.com
Ownership: Private

Web Site: ViraCyte
Employees:
Symbol: 
 









Company News
//-->